Optimization of Drug Loading Procedures and Characterization of Liposomal Formulations of Two Novel Agents Intended for Boron Neutron Capture Therapy (BNCT)
- 1 January 1999
- journal article
- research article
- Published by Taylor & Francis in Journal of Liposome Research
- Vol. 9 (1) , 53-79
Abstract
The characterization of two liposomal formulations of boronated DNA-interacting agents has been performed. It is shown that the two boronated drugs, WSA-Water Soluble Acridine and WSP-Water Soluble Phenantridine, can be encapsulated within unilamellar sterically stabilized liposomes with high drug-to-lipid ratios (up to 0.50:1 (mol:mol)), using transmembrane pH gradients. The steric stabilization of the liposomes was accomplished by the addition of DSPE-PEG(2000) (PEG-lipid) to DSPC/Cho lipid mixtures and the composition used was DSPC: Cho: DSPE-PEG 55:40:5 (moI%). The loading of the drugs resulted in drug precipitation in the liposomal aqueous core as observed by cryo-transmission electron microscopy (c-TEM). Moreover, it is shown that when pH gradients across the bilayer were used for remote loading of WSP or when ammonium sulfate gradients were used for remote loading of WSA, the formation of small bilayer fragments (discs) was induced. We present compelling evidence that the formation of discs is a consequence of precipitate growth in the liposomal interior. The precipitate growth causes some of the liposomes to rupture resulting in the above mentioned disc-formation and a substantial decrease in trapping efficiency. The in vitro stability of the drug loaded liposomes was excellent, both in buffer and in 25% human serum. For most of the formulations, the release of the drugs was below or around 10% after 24 hours at 37oC. Furthermore, the influence of initial internal pH and internal buffering capacity on release properties of WSA and WSP were investigated. It is shown that the release profiles of the drugs can be controlled, to a large extent, by varying the composition of the internal liposomal aqueous phase.Keywords
This publication has 52 references indexed in Scilit:
- Selective boron drug delivery to brain tumors for boron neutron capture therapyAdvanced Drug Delivery Reviews, 1997
- Liposomes as drug delivery vehicles for boron agentsJournal of Neuro-Oncology, 1997
- Development and in Vitro Studies of Epidermal Growth Factor−Dextran Conjugates for Boron Neutron Capture TherapyBioconjugate Chemistry, 1996
- Liposomal formulations containing sodium mercaptoundecahydrododecaborate (BSH) for boron neutron capture therapyJournal of Microencapsulation, 1996
- Synthesis and Characterization of Oligomeric nido-Carboranyl Phosphate Diester Conjugates to Antibody and Antibody Fragments for Potential Use in Boron Neutron Capture Therapy of Solid TumorsBioconjugate Chemistry, 1994
- Na3[B20H17NH3]: synthesis and liposomal delivery to murine tumors.Proceedings of the National Academy of Sciences, 1994
- Radiation dose heterogeneity in receptor and antigen mediated boron neutron capture therapyRadiotherapy and Oncology, 1994
- The Role of Chemistry in the Development of Boron Neutron Capture Therapy of CancerAngewandte Chemie International Edition, 1993
- Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy.Proceedings of the National Academy of Sciences, 1991
- Application of boronated anti-CEA immunoliposome to tumour cell growth inhibition in in vitro boron neutron capture therapy modelBritish Journal of Cancer, 1991